KOTLER KEVIN 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 08:20 am Purchase |
2024-02-12 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,716,242 4.100% |
594,142 (+19.03%) |
Filing |
| 2023-03-09 4:13 pm Purchase |
2023-02-14 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,122,100 5.100% |
265,110 (+9.28%) |
Filing |
| 2023-02-13 4:58 pm Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 2,856,990 4.600% |
-583,222 (-16.95%) |
Filing |
| 2022-06-06 4:57 pm Purchase |
2022-05-26 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,440,212 5.800% |
3,440,212 (New Position) |
Filing |